Sign in

CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
202726770
Phone
862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
  1. 4 Grant or award Chief Business Officer acquired 4,571 shares (grant or award)
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 4 Shares withheld for taxes Chief Business Officer gave up 4,229 shares (to pay taxes)
  4. 4 Shares withheld for taxes Director gave up 17,898 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Scientific Officer gave up 4,748 shares (to pay taxes)
  6. 8-K Event Material agreement
  7. 424B5 Offering Prospectus
  8. 4 Shares withheld for taxes Chief Business Officer gave up 3,855 shares (to pay taxes)
  9. 4 Shares withheld for taxes Director gave up 17,984 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Scientific Officer gave up 4,373 shares (to pay taxes)
  11. 4 Open-market buy Director bought 5,000 shares at $4.08 ($20,410)
  12. 4 Shares withheld for taxes Chief Business Officer gave up 2,475 shares (to pay taxes)
  13. 4 Open-market buy Director bought 500 shares at $4.24 ($2,118)
  14. 4 Open-market buy Director bought 527 shares at $3.80 ($2,003)
  15. 4 Open-market buy Director bought 12,500 shares at $4.10 ($51,250)
  16. 4 Open-market buy Director bought 12,500 shares at $4.13 ($51,569)
  17. 8-K Event Regulation FD disclosure · Other events
  18. EFFECT Other Notice of Effectiveness
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. 4 Derivatives Options or other derivatives

Page 4 of 74 · 1,466 filings